◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Adicon Holdings Limited (9860) Financial History

Name: Adicon Holdings Limited (9860) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-10

Adicon Holdings Limited (9860) operates in the Diagnostics & Research industry and is headquartered in Hangzhou, China with about 5,071 employees. Its market capitalization is roughly CNY 3 billion. In the fiscal year ended 2025-12-31, 9860 reported CNY 2.6B in revenue and CNY 18M in net income.

Adicon Holdings Limited, an investment holding company, provides medical testing services in the People's Republic of China. The company offers testing services primarily to hospitals and health check centers through an integrated network of self-operated laboratories; and research and clinical trial services.

Interactive charts & full statements →

9860 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 2.6B	CNY 2.9B	CNY 3.3B	CNY 4.9B	—
Gross Profit	CNY 952M	CNY 1.1B	CNY 1.4B	CNY 1.9B	—
Operating Income (EBIT)	CNY 157M	CNY 271M	CNY 482M	CNY 904M	—
Net Income	CNY 18M	CNY 47M	CNY 235M	CNY 681M	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

9860 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	—	—	—	(CNY 865M)	(CNY 453M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

9860 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 4.8B	CNY 4.7B	CNY 4.6B	CNY 4.9B	—
Total Liabilities	CNY 3.0B	CNY 2.9B	CNY 2.7B	CNY 4.2B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 9860 viewer.

Other Companies in Diagnostics & Research

BLLN · BillionToOne, Inc. — $4 billion
ADPT · Adaptive Biotechnologies Corporation — $4 billion
VCYT · Veracyte, Inc. — $4 billion
GRAL · GRAIL, Inc. — $3 billion
CDNA · CareDx, Inc. — $2 billion
2427 · Guanze Medical Information Industry (Holding) Co., Ltd. — $2 billion
NEO · NeoGenomics, Inc. — $2 billion
WGS · GeneDx Holdings Corp. — $2 billion

← 9858 All “0-9” companies 9861 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.